Rite Aid Execs Dodge Investor Suit Over Opioid Litigation
Several of Rite Aid's executives have escaped a securities fraud suit accusing them of making misleading statements about the pharmacy retailer's opioid-related liabilities, with a Pennsylvania federal court finding they sufficiently...To view the full article, register now.
Already a subscriber? Click here to view full article